[Depressive syndromes in childhood and adolescence. Symptomatology, etiology and prognosis].
D000293:Adolescent; D000367:Age Factors; D002648:Child; D002657:Child Development; D002665:Child Psychiatry; D002673:Child, Hospitalized; D002675:Child, Preschool; D003295:Convulsive Therapy; D003863:Depression / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D003984:Dibenzazepines / Q000627:therapeutic use; D005190:Family; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use; D007223:Infant; D007360:Intelligence; D008297:Male; D009034:Mother-Child Relations; D010672:Phenytoin / Q000627:therapeutic use; D011606:Psychosexual Development; D011613:Psychotherapy; D011615:Psychotherapy, Group; D012561:Schizophrenia, Childhood / Q000175:diagnosis; D012737:Sex Factors; D012801:Sibling Relations; D013405:Suicide; D014149:Tranquilizing Agents / Q000627:therapeutic use
D003984:Dibenzazepines; D014149:Tranquilizing Agents; D010672:Phenytoin; D007099:Imipramine
Depressive Syndrome im Kindes- und Jugendalter. Beitrag zur Symptomatologie Genese und Prognose.